Talking therapy may tame panic attacks in teens
NCT ID NCT00705380
First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time
Summary
This study tests whether a type of talk therapy called cognitive behavioral therapy (CBT) can help teenagers with panic disorder. The therapy includes 11 weekly sessions designed to change how teens think about and react to panic symptoms. Participants track their anxiety daily. The goal is to reduce panic attacks and related anxiety.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- cognitive behavioral therapy with panic control treatment
- What this could lead to
- If effective, this therapy could provide a non-drug treatment option for teens with panic disorder, reducing panic attacks and anxiety.
- What could go wrong
- This is a small early study with only 25 participants, so results may not apply to all teens. The therapy requires commitment to weekly sessions and daily self-monitoring.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
25 people
The number who actually took part.
- Start date
-
Jul 1998
- Finished
-
Oct 2004
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
12 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Meets DSM-IV criteria for principal diagnosis of panic disorder or panic disorder with agoraphobia prior to treatment * If on medication, must undergo a 1-month stabilization period for benzodiazepines or 3-month stabilization period for selective serotonin reuptake inhibitors or tricyclics before study entry Exclusion Criteria: * Positive diagnosis of schizophrenia, pervasive developmental disorder, organic brain syndrome, or mental retardation * Current suicidal ideation * Refusal of parent to accept random assignment to treatment condition * Refusal of parent or adolescent to accept stabilization of medication
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Panic disorder are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston University
Boston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tailored brain stimulation quiet anxiety that drugs Can't?
- Rewriting traumatic panic memories: a new therapy on trial
- Can rewiring fear expectations stop anxiety from coming back?
- Can an AI coach help therapists treat depression and anxiety online?
- Can a unified therapy tame both addiction and emotional disorders?
- Can online therapy or parent coaching ease childhood anxiety? a head-to-head trial aims to find out.